The Research Advancement of Vitamin D and Hypertension

Home > Archive>Volume 24, Issue 8, 2016 >860-864

The Research Advancement of Vitamin D and Hypertension
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        ZHANG LinZHANG Lin
Shengjing Hospital of China Medical University,Shenyang, Liaoning 110000,China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
FU PengFU Peng
Shengjing Hospital of China Medical University,Shenyang, Liaoning 110000,China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:Shengjing Hospital of China Medical University,Shenyang, Liaoning 110000,China)
Clc Number:R544.1
Fund Project:

Article

Figures

Metrics

Reference [33]

Cited by

Materials

Comments

Abstract:

Vitamin D deficiency is a common phenomenon in the world, and the current research has shown that vitamin D is closely related with a variety of diseases. Vitamin D is used by acting on the vitamin D receptor. A large number of epidemiological studies and clinical trials show that there are closely link between vitamin D deficiency and hypertension, coronary artery disease, heart failure and cardiovascular adverse events. The relationship between Vitamin D and hypertension involves many aspects, but its specific mechanism is unclear. This article will review the relationship between Vitamin D and hypertension.

Key words:Hypertension; Vitamin D; Vitamin D Deficiency

Reference

[1] Holick M F.High prevalence of vitamin D inadequacy and implications for health.Mayo Clin Proc, 6,1: 353-373.

[2] Judd S E, Tangpricha V.Vitamin D deficiency and risk forcardiovascular disease.Am J Med Sci, 9,8(1): 40-44.

[3] 吉薇, 蒋雄京.维生素D状态与心血管危害.心血管病学进展, 0,1(3): 327-331.

[4] Holick MF.Vitamin D deficiency .N Engl J Med, 7,7(3): 266-281.

[5] Kim MS, Fujiki R, Murayama A, et al.1Alpha, 25(OH)₂D3 induced transrepression by vitamin D receptor through E-boxtype elements in the human parathyroid hormone gene promoter .Mol Endocrinol, 7,1: 334-342.

[6] Carlberg C, Campbell MJ.Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor .Steroids, 3,8: 127-136.

[7] Bouillon R, Carmeliet G, Verlinden L, et al.Vitamin D and human health: lessons from vitamin D receptor null mice .Endocr Rev, 8,9: 726-776.

[8] Bischoff A, Giovannucci E, Willett C, et al.Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.Am J ClinNutr, 6,4(1): 18-28.

[9] Bell C.Ultraviolet light may contribute to geographic and racial blood pressure differences .Hypertension, 7,0(2): 150-156.

[10] Borges AC, Feres T, Vianna LM, et al.Cholecalciferol treatment restores the relaxant responses of spontaneously hypertensive rat arteries to bradykinin.Pathophysiology, 2,8(4): 263-268.

[11] Forman JP.Effect of vitamin D supplementation on blood pressure in blacks .Hypertension , 3,1(4): 779-785.

[12] Scragg R, Slow S, Stewart AW, et al.Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial .Hypertension, 4,4(4): 725-730.

[13] Li YC, Qiao G, et al.Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.Steroid Biochem Mol Biol, 4,9-90(1-5): 387-392.

[14] Sugden JA, Davies JI, Witham MD, et al.Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels.Diabet Med, 8,5(3): 320-325.

[15] Vaidya A, Forman JP, Williams JS.Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension .Hum Hypertens, 1,5(11): 672-678.

[16] Suzuki Y, Ichiyama T.Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D (3) in human coronary arterial endothelial cells:Implication for the treatment of Kawasaki disease.Steroid Biochem Mol Biol, 9,3(1-2): 134-138.

[17] Equals O, Naiki Y, Shapiro AM, et al.1,5-Dihydroxy vitamin D inhibits lipopolysaccharide induced immune activation in human endothelialcells.Clin Exp Immunol, 6,3(1): 58-64.

[18] Jablonski KL, Chonchol M.25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults.Hypertension, 1,7(1): 63-69.

[19] Meems L M, Vander Harst P, Van Gilst W H, et al.Vitamin D biology in heart failure:molecular mechanisms and systematic review.Curr Drug Targets, 1,2(1): 29-41.

[20] Wang L, Manson JE, Buring JE, et al.Dietary intake of dairy products,calcium,and vitamin D and the risk of hypertension in middleaged and older women .Hypertensio n, 8,1(4): 1 073-079.

[21] Scragg R, Sowers M, Bell C.Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey .American Journal of Hypertension, 7,0(7): 713-719.

[22] Forman JP, Edward G, Holmes MD, et al.Plasma 25-hydroxyvitamin D levels and risk of incident hypertension .Hypertension, 7,9(5): 1 063-069.

[23] Bernini G, Carrara D, Bacca A, et al.Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls.J Endocrinol Invest, 3,6(4): 216-220.

[24] Ke L, Mason RS, Mpofu E, et al.Vitamin D and Parathyroid Hormone Status in a Representative Population Living in Macau, China .Journal of Steroid Biochemistry & Molecular Biology, 5,8: 261-268.

[25] Mao X, Zheng H, Liu Z, et al.Analysis of 25(OH)D serum concentrations of hospitalized elderly patients in the Shanghai area .PLoS One, 4,9 : e90 729.

[26] Jono S, Shioi A, Ikari Y, et al.Vascular calcification inchronic kidney disease.Bone Miner Metab, 6,4(2): 176-181.

[27] Lind L, Hanni A, Lithell H, et al.Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.Am J Hypertens, 5,8(9): 894-901.

[28] Chiu KC, Chu A, Go VL, et al.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.Am J Clin Nutr, 4,9(5): 820-825.

[29] Mitri J,Dawson-Hughes B,Hu FB,et al.Effects of vitamin D and calcium supplementation on pancreatic β－cell function,insulin sensitivity,and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.Am J Clin Nutr, 1,4: 486-494.

[30] Chen S, Ni XP, Humphreys MH, et al.1,5 dihydroxyvitamin d amplifies type a natriuretic peptide receptor expression and activity in target cells.Am Soc Nephrol, 5,6(2): 329-333.

[31] Lacroix AZ, Kotchen J, Anderson G, et al.Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial.Gerontol A Biol Sci Med Sci, 9,4: 559-556

[32] Nasri H, Behradmanesh S, Ahmadi A, et al.Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial .Journal of Nephropathology, 4,3(1): 29-33.

[33] Arora P, Song Y, Duesk J, et al.Vitamin D therapy in individuals with perhypertension or hypertension .Circulation, 5,1: 254-262.

Get Citation

ZHANG Lin, FU Peng. The Research Advancement of Vitamin D and Hypertension[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(8):860-864.

Copy

Article Metrics

Abstract:1410
PDF: 2276
HTML: 0
Cited by: 0

History

Received:August 11,2015
Revised:October 28,2015
Adopted:
Online: July 25,2016
Published:

Policies & Instructions

Get Citation

Related Videos

Share

Article Metrics

History

Article QR Code